Updated Monday, 12/14. Six IPOs and five SPACs are scheduled to raise $2.8 billion in the week ahead as the IPO market starts to slow down before the holidays. Bargain e-commerce platform Wish (WISH) plans to raise $1.1...read more
Updated Monday, 7/13. Nine IPOs and one SPAC plan to raise $1.5 billion in the week ahead, led by health insurance marketplace GoHealth (GOCO). More deals could join the IPO calendar in the week ahead, including Apple workflow...read more
Five IPOs and one SPAC went public this past week led by Royalty Pharma (RPRX), which completed the largest US IPO of 2020 to date. Healthcare continued to dominate, with all five IPOs coming from the sector. Royalty Pharma (RPRX)...read more
Forma Therapeutics, a Phase 1 biotech developing therapies for SCD and hematologic diseases, raised $278 million in an upsized IPO by offering 13.9 million shares at $20, well above the range of $16 to $18. The company originally planned to offer 11.8 million...read more
US IPO Week Ahead: The IPO market makes a holiday WISH in a 6 IPO week
Updated Monday, 12/14. Six IPOs and five SPACs are scheduled to raise $2.8 billion in the week ahead as the IPO market starts to slow down before the holidays. Bargain e-commerce platform Wish (WISH) plans to raise $1.1...read more
US IPO Week Ahead: GoHealth takes the lead in a 9 IPO Week
Updated Monday, 7/13. Nine IPOs and one SPAC plan to raise $1.5 billion in the week ahead, led by health insurance marketplace GoHealth (GOCO). More deals could join the IPO calendar in the week ahead, including Apple workflow...read more
US IPO Weekly Recap: Royalty Pharma takes the crown in 5 IPO week
Five IPOs and one SPAC went public this past week led by Royalty Pharma (RPRX), which completed the largest US IPO of 2020 to date. Healthcare continued to dominate, with all five IPOs coming from the sector. Royalty Pharma (RPRX)...read more
Forma Therapeutics prices upsized IPO at $20, well above the range
Forma Therapeutics, a Phase 1 biotech developing therapies for SCD and hematologic diseases, raised $278 million in an upsized IPO by offering 13.9 million shares at $20, well above the range of $16 to $18. The company originally planned to offer 11.8 million...read more